Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO0012
Host Cell : HEK293T Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO0012 |
| Description | This cell line is engineered to stably overexpress the human CD274 in HEK293T cells. |
| Target Gene | CD274 |
| Gene Species | Homo sapiens (Human) |
| Host Cell | HEK293T |
| Host Cell Species | Homo sapiens (Human) |
| Source | HEK293 |
| Applications |
1. Studying the interactions between immune cells and cancer cells 2. Studying the mechanisms of resistance to immune checkpoint blockade 3. High-throughput screening 4. Drug target validation |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | CD274 CD274 molecule [ Homo sapiens ] |
| Gene Symbol | CD274 |
| Synonyms | CD274; CD274 molecule; CD274 antigen , PDCD1LG1, programmed cell death 1 ligand 1; programmed cell death 1 ligand 1; B7 homolog 1; B7 H; B7 H1; B7H1; PD L1; PDL1; CD274 antigen; PDCD1 ligand 1; programmed death ligand 1; B7-H; PD-L1; PDCD1L1; PDCD1LG1; MGC142294; MGC142296; |
| Gene ID | 29126 |
| Uni Prot ID | Q9NZQ7 |
| m RNA Refseq | BC113734 |
| Chromosome Location | 9p24.1 |
| Function | protein binding; protein tyrosine phosphatase activity; receptor activity; |
| Pathway | Adaptive Immune System, organism-specific biosystem; Cell adhesion molecules (CAMs), organism-specific biosystem; Cell adhesion molecules (CAMs), conserved biosystem; Costimulation by the CD28 family, organism-specific biosystem; Immune System, organism-specific biosystem; PD-1 signaling, organism-specific biosystem; |
| MIM | 605402 |
This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.
A: The primary objective behind developing the Human CD274 Stable Cell Line-HEK293 was to provide a consistent and reliable model system for studying the expression, regulation, and function of CD274. This cell line aids researchers in understanding the role of CD274 in immune checkpoint regulation and other cellular processes.
A: The Human CD274 Stable Cell Line-HEK293 exhibits enhanced and consistent expression of CD274 compared to native HEK293 cells, which can be quantified using methods like Western blotting or flow cytometry.
A: Yes, the Human CD274 Stable Cell Line-HEK293 can be effectively used for drug screening. Its consistent expression of CD274 makes it an ideal candidate for evaluating potential immune checkpoint inhibitors or other therapeutic compounds targeting CD274.
A: The Human CD274 Stable Cell Line-HEK293 should be cultured under standard mammalian cell culture conditions, with the addition of a specific selection antibiotic to ensure stable CD274 expression and maintain the modified phenotype.
A: While the Human CD274 Stable Cell Line-HEK293 is designed to primarily alter CD274 expression, researchers should routinely monitor the cells. Any significant morphological or growth rate changes would be product-specific and should be detailed in the product's accompanying documentation.
A: To validate the functionality of CD274 in the Human CD274 Stable Cell Line-HEK293, researchers can utilize ligand-binding assays, co-culture assays with T cells to assess immune cell interactions, or investigate downstream signaling pathways triggered by CD274.
A: Specific studies or publications would be dependent on the research community's usage. Researchers interested in such data should consult scientific literature databases or reach out to the product's manufacturer for references.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.